Page last updated: 2024-08-21

quinazolines and Down Syndrome

quinazolines has been researched along with Down Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adachi, S; Endo, M; Ito, E; Kanegane, H; Kanezaki, R; Kiyoi, H; Kojima, S; Mano, H; Migita, M; Miura, M; Morinaga, S; Nakano, T; Sato, T; Terui, K; Toki, T; Xu, G	1

Other Studies

1 other study(ies) available for quinazolines and Down Syndrome

Article	Year
Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome. British journal of haematology, 2008, Volume: 141, Issue:5 Topics: Base Sequence; Cell Proliferation; Dose-Response Relationship, Drug; Down Syndrome; Female; Humans; Janus Kinase 3; Leukemia, Megakaryoblastic, Acute; Male; Molecular Sequence Data; Mutation; Myeloproliferative Disorders; Neoplasm Proteins; Quinazolines; Signal Transduction; Tumor Cells, Cultured	2008

Article

Year

Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome.

British journal of haematology, 2008, Volume: 141, Issue:5

Topics: Base Sequence; Cell Proliferation; Dose-Response Relationship, Drug; Down Syndrome; Female; Humans; Janus Kinase 3; Leukemia, Megakaryoblastic, Acute; Male; Molecular Sequence Data; Mutation; Myeloproliferative Disorders; Neoplasm Proteins; Quinazolines; Signal Transduction; Tumor Cells, Cultured

2008